Living EuroGuiDerm Guideline for the systemic treatment of psoriasis vulgaris
 

The general recommendations developed in this guideline are based on the Living Cochrane review published in January 2020. With new evidence and new results becoming available, the guideline development group will consider these and decide if and when an update is necessary. This will also be the case for the recommendations for specific clinical and comorbid situations. 

Download entire guideline in the most up-to-date version:

Download
314
Last updated
Changes since last version
Download
Introduction, scoping, population and targeted users
07/2020
Original version
Disease severity and treatment goals
07/2020
Original version
Methods and evidence section
07/2020
Original version
Main Recommendations and Decision Grid
07/2020
Original version
Strength and limitations
07/2020
Original version
References
07/2020
Original version
Abbreviations
07/2020
Original version

Contains intructions for use, recommendations for lab controls, adverse drug reactions, special consideration during treatment, important contraindications and drug interactions

Last updated
Changes since last version
Download
Acitretin
07/2020
Original version
Ciclosporin
07/2020
Original version
Fumarates
07/2020
Original version
Methotrexate
07/2020
Original version
Adalimumab
07/2020
Original version
Apremilast
07/2020
Original version
Brodalumab
07/2020
Original version
Certolizumab – Pegol
07/2020
Original version
Etanercept
07/2020
Original version
Guselkumab
07/2020
Original version
Infliximab
07/2020
Original version
Ixekizumab
07/2020
Original version
Risankizumab
07/2020
Original version
Secukinumab
07/2020
Original version
Tildrakizumab
07/2020
Original version
Ustekinumab
07/2020
Original version
Biosimilars
07/2020
Original version
Newly approved medications and treatments in the pipeline
07/2020
Original version
Last updated
Changes since last version
Download
Psoriatic arthritis
07/2020
Original Version
Inflammatory bowel disease
07/2020
Original Version
Cancer
07/2020
Original Version
Depression
07/2020
Original Version
Diabetes
07/2020
Original Version
Heart disease
07/2020
Original Version
Kidney disease
07/2020
Original Version
Neurological diseases
07/2020
Original Version
Viral Hepatitis
07/2020
Original Version
Tuberculosis: Screening
07/2020
Original Version
Tuberculosis: Management
07/2020
Original Version
Wish for child / Pregnancy
07/2020
Original Version
Vaccinations
07/2020
Original Version
Covid-19
09/2020
Minor changes
Inmunogenicity
07/2020
Original Version
Last updated
Changes since last version
Download
Methods Report
07/2020
Original Version
IFPA Guideline
07/2020
Original Version
Implementation slides
07/2020
Original Version